Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Kamangar F, Nasrollahzadeh D, Safiri S, Sepanlou SG, Fitzmaurice C, Ikuta KS et al (2020) The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 5(6):582–597
2. Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP (2011) Oesophagogastric junction adenocarcinoma: Which therapeutic approach? Lancet Oncol. 12(3):296–305
3. Mariette C, Dahan L, Mornex F, Maillard E, Thomas PA, Meunier B et al (2014) Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: Final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 32(23):2416–2422
4. Khan O, Nizar S, Vasilikostas G, Wan A (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. J Thorac Dis. 4(5):465–466
5. Van Der Sluis PC, Grimminger PP, Van Hillegersberg R, Ruurda JPH (2019) Hybrid minimally invasive esophagectomy for esophageal cancer: Less is more. J Thorac Dis. 11:S1935–S1937